NextBio Platform for Interpreting Genomic Data in Translational Research and Clinical Applications Passes HIPAA Audit

Published: Aug 08, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--NextBio announced today that their newly launched NextBio Clinical platform has successfully passed an independent 3rd party audit of NextBio’s security controls, meeting HIPAA (the federally mandated Health Insurance Portability and Accountability Act) requirements. NextBio demonstrated the implementation of physical, technical, and administrative controls to assure the confidentiality, integrity, and availability of electronic protected health information (ePHI) in its cloud-based NextBio Clinical platform. This successful HIPAA audit enables NextBio Clinical to host protected patient information as it integrates electronic medical records (EMRs) to further the use of genomics for translational medicine and research, as well as in the clinic. NextBio offers the world’s largest repository of curated and correlated molecular and clinical data.

Back to news